EMR Adverse Drug Event Detection for Pharmacovigilance

用于药物警戒的 EMR 药物不良事件检测

基本信息

  • 批准号:
    9123554
  • 负责人:
  • 金额:
    $ 33.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2017-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Adverse drug events (ADEs) result in substantial patient morbidity and lead to over 100,000 deaths yearly. The timely identification of previously unknown toxicities of cancer drugs is an important, unsolved problem. In the United States, 20% of the 548 drugs introduced into the market between 1975 and 1999 were either withdrawn or acquired a new "black box" warning during the 25-year period following initial approval by the Food and Drug Administration. Adverse drug events are an important cause of morbidity and mortality in patients, yet 95% of ADEs are unreported, leading to delays in the detection of previously unknown ADEs and underestimation of the risk to known ADEs. It is known that Electronic Medical Record (EMR), discharge summaries, and lab results contain ADE information and biomedical natural language processing (BioNLP) provides automated tools that facilitate chart review and thus improve patient surveillance and post-marketing pharmacovigilance. The objectives for this proposal are to develop "intelligent" BioNLP approaches to extract disease, medication, and structured ADE information from EMRs, and then evaluate extracted ADEs for detecting known ADE types as well as clinically unrecognized or novel ADEs whose pattern or effect have not been previously identified.
描述(由申请人提供):药物不良事件(ADE)导致大量患者发病,每年导致超过100,000例死亡。及时识别癌症药物的先前未知的毒性是一个重要的,未解决的问题。在美国,1975年至1999年期间引入市场的548种药物中有20%在食品和药物管理局首次批准后的25年期间被撤回或获得新的“黑匣子”警告。药物不良事件是导致患者发病和死亡的重要原因,但95%的ADE未报告,导致先前未知ADE的检测延迟和已知ADE风险的低估。众所周知,电子病历(EMR)、出院总结和实验室结果包含ADE信息,生物医学自然语言处理(BioNLP)提供了自动化工具,有助于病历审查,从而改善患者监测和上市后药物警戒。该提案的目的是开发“智能”BioNLP方法,从EMR中提取疾病、药物和结构化ADE信息,然后评价提取的ADE,以检测已知ADE类型以及临床上未识别或新型ADE(其模式或效应先前尚未确定)。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HONG YU其他文献

HONG YU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HONG YU', 18)}}的其他基金

Social and behavioral determinants of health and Alzheimer’s Disease: Cohort study of the US military veteran population
健康和阿尔茨海默病的社会和行为决定因素:美国退伍军人群体的队列研究
  • 批准号:
    10591049
  • 财政年份:
    2023
  • 资助金额:
    $ 33.7万
  • 项目类别:
Improving Suicide Prediction using NLP-Extracted Social Determinants of Health
使用 NLP 提取的健康社会决定因素改善自杀预测
  • 批准号:
    10656321
  • 财政年份:
    2020
  • 资助金额:
    $ 33.7万
  • 项目类别:
Improving Suicide Prediction using NLP-Extracted Social Determinants of Health
使用 NLP 提取的健康社会决定因素改善自杀预测
  • 批准号:
    10428629
  • 财政年份:
    2020
  • 资助金额:
    $ 33.7万
  • 项目类别:
Improving Suicide Prediction using NLP-Extracted Social Determinants of Health
使用 NLP 提取的健康社会决定因素改善自杀预测
  • 批准号:
    10251336
  • 财政年份:
    2020
  • 资助金额:
    $ 33.7万
  • 项目类别:
Improving Suicide Prediction using NLP-Extracted Social Determinants of Health
使用 NLP 提取的健康社会决定因素改善自杀预测
  • 批准号:
    10100989
  • 财政年份:
    2020
  • 资助金额:
    $ 33.7万
  • 项目类别:
Resource Curation and Evaluation for EHR Note Comprehension
EHR 笔记理解的资源管理和评估
  • 批准号:
    9925807
  • 财政年份:
    2018
  • 资助金额:
    $ 33.7万
  • 项目类别:
Resource Curation and Evaluation for EHR Note Comprehension
EHR 笔记理解的资源管理和评估
  • 批准号:
    9794757
  • 财政年份:
    2018
  • 资助金额:
    $ 33.7万
  • 项目类别:
Systems for Helping Veterans Comprehend Electronic Health Record Notes
帮助退伍军人理解电子健康记录笔记的系统
  • 批准号:
    9768225
  • 财政年份:
    2015
  • 资助金额:
    $ 33.7万
  • 项目类别:
Systems for Helping Veterans Comprehend Electronic Health Record Notes
帮助退伍军人理解电子健康记录笔记的系统
  • 批准号:
    9894743
  • 财政年份:
    2015
  • 资助金额:
    $ 33.7万
  • 项目类别:
EHR Anticoagulants Pharmacovigilance
EHR 抗凝剂药物警戒
  • 批准号:
    9190384
  • 财政年份:
    2014
  • 资助金额:
    $ 33.7万
  • 项目类别:

相似海外基金

Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10707830
  • 财政年份:
    2023
  • 资助金额:
    $ 33.7万
  • 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
  • 批准号:
    479728
  • 财政年份:
    2023
  • 资助金额:
    $ 33.7万
  • 项目类别:
    Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
  • 批准号:
    10884567
  • 财政年份:
    2023
  • 资助金额:
    $ 33.7万
  • 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
  • 批准号:
    10751964
  • 财政年份:
    2023
  • 资助金额:
    $ 33.7万
  • 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
  • 批准号:
    486321
  • 财政年份:
    2022
  • 资助金额:
    $ 33.7万
  • 项目类别:
    Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10676786
  • 财政年份:
    2022
  • 资助金额:
    $ 33.7万
  • 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
  • 批准号:
    10440970
  • 财政年份:
    2022
  • 资助金额:
    $ 33.7万
  • 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
  • 批准号:
    10642998
  • 财政年份:
    2022
  • 资助金额:
    $ 33.7万
  • 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
  • 批准号:
    10482465
  • 财政年份:
    2022
  • 资助金额:
    $ 33.7万
  • 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
  • 批准号:
    10191053
  • 财政年份:
    2020
  • 资助金额:
    $ 33.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了